Research activities are co-ordinated from a purpose build research mezzanine within the QENSIU funded by a £1.2 million grant from a SRIF infrastructure scheme. This facility provides a base for academics, clinical scientists, post-doctoral staff and PhD students. There is a full range of research and laboratory facilities at partner institutions. This clinical and academic combination optimises the efficacy of our translational research programme moving innovative clinical and/or technological solutions effectively into clinical practice to the benefit of patients. This collaboration is unique in the UK and rare worldwide.
Currently recruiting patients to the following studies
- Patient self-managed BCI-FES (supported by Digital Health & Care Institute)
- Different Stimulation Patterns to Reduce Muscle Fatigue during FES
- Ultrasound Imaging to Characterise Muscle in Spinal Cord Injury (supported by EPSRC DTA PHD scholarship)
- Early intervention to reduce bone loss after spinal cord injury (supported by ISRT)
- BrainTrain Home Based Pain Treatment (suported by the Inspire Foundation)
European Multicenter Study about Spinal Cord Injury (EMSCI)
- Nogo Inhibition in Spinal Cord Injury (NISCI)
- SCIM IV validation
- Non-invasive spinal cord stimulation combined with activity-based therapy in chronic complete high level spinal cord injury (funded by ISRT)
- Mechanism of neuropathic pain following spinal cord injury: role of the spinothalamic tract (suported by the Inspire Foundation)
We are committed to
- Producing high quality evidence-based research that is relevant and impactful.
- Developing, supporting and nurturing the next generation of leaders
- Working collaboratively, through exchanging ideas and sharing opinions to tackle current challenges in SCI research and practice.
Our Strategy (2017-2022)
We will strengthen our existing research portfolio by focusing on synergistic working across our research themes.
SCISCI has ambitious plans to expand on the present high quality, innovative research portfolio to become an International Centre of Excellence in SCI research.